Lung cancer in never smokers—the East Asian experience

Por Zhou, Fei, Zhou, Caicun
Publicado no Transl Lung Cancer Res (2018)

Pros: the present classification of mucinous adenocarcinomas of the lung

Por Dacic, Sanja
Publicado no Transl Lung Cancer Res (2017)

Alterations of fecal bacterial communities in patients with lung cancer

Por Zhang, Wei-Quan, Zhao, Shu-Kang, Luo, Jun-Wen, Dong, Xiao-Peng, Hao, Ying-Tao, Li, Hui, Shan, Lei, Zhou, Yong, Shi, Hu-Bo, Zhang, Zai-Yun, Peng, Chuan-Liang, Zhao, Xiao-Gang
Publicado no Am J Transl Res (2018)

Changing equipoise in the landscape of radiation for oligometastatic lung cancer

Por Schroeder, Samuel R., Leenders, Michael, Iyengar, Puneeth, de Ruysscher, Dirk
Publicado no Transl Lung Cancer Res (2019)

Molecular testing in lung cancer in the era of precision medicine

Por Popper, Helmut H., Ryska, Ales, Tímár, József, Olszewski, Wlodzimierz
Publicado no Transl Lung Cancer Res (2014)

Global trends of lung cancer mortality and smoking prevalence

Por Islami, Farhad, Torre, Lindsey A., Jemal, Ahmedin
Publicado no Transl Lung Cancer Res (2015)

Lung cancer biomarker testing: perspective from Europe

Por Thunnissen, Erik, Weynand, Birgit, Udovicic-Gagula, Dalma, Brcic, Luka, Szolkowska, Malgorzata, Hofman, Paul, Smojver-Ježek, Silvana, Anttila, Sisko, Calabrese, Fiorella, Kern, Izidor, Skov, Birgit, Perner, Sven, Dale, Vibeke G., Eri, Zivka, Haragan, Alex, Leonte, Diana, Carvallo, Lina, Prince, Spasenja Savic, Nicholson, Siobhan, Sansano, Irene, Ryska, Ales
Publicado no Transl Lung Cancer Res (2020)

Animal Models in Carotenoids Research and Lung Cancer Prevention

Por Kim, Jina, Kim, Yuri
Publicado em 2011

LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer

Por Zhang, Yuanyuan, Yang, Rui, Lian, Jianchun, Xu, Haiyan
Publicado no Am J Transl Res (2016)

Lung cancer screening and shared decision making in cancer survivors: the long and winding road

Por Rivera, M. Patricia, Henderson, Louise M.
Publicado no Transl Lung Cancer Res (2019)

Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?

Por Bertolaccini, Luca, Terzi, Alberto, Ricchetti, Francesco, Alongi, Filippo
Publicado no Ann Transl Med (2015)

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

Por van den Heuvel, Michel M, Verheij, Marcel, Boshuizen, Rogier, Belderbos, José, Dingemans, Anne-Marie C, De Ruysscher, Dirk, Laurent, Julien, Tighe, Robert, Haanen, John, Quaratino, Sonia
Publicado no J Transl Med (2015)

Update on large cell neuroendocrine carcinoma

Por Hiroshima, Kenzo, Mino-Kenudson, Mari
Publicado no Transl Lung Cancer Res (2017)

LncRNA FOXC2 antisense transcript accelerates non-small-cell lung cancer tumorigenesis via silencing p15

Por Sun, Zhe, He, Chaozhu, Xiao, Miao, Wei, Binbin, Zhu, Yuanzhe, Zhang, Guangxing, Zhou, Huyan, Yuan, Jun, Hu, Xiaju, Yi, Yuli
Publicado no Am J Transl Res (2019)

Is overall survival still the primary endpoint in maintenance non-small cell lung cancer studies? An analysis of phase III randomised trials

Por Petrelli, Fausto, Barni, Sandro
Publicado no Transl Lung Cancer Res (2013)

Tumor-associated macrophages in stage IIIA pN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery

Por Feng, Po-Hao, Yu, Chih-Teng, Wu, Chin-Yang, Lee, Meng-Jung, Lee, Wei-Hwa, Wang, Liang-Shun, Lin, Shu-Min, Fu, Jen-Fen, Lee, Kang-Yun, Yen, Tzung-Hai
Publicado em 2014

Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines

Por Codony-Servat, Jordi, Viteri, Santiago, Codony-Servat, Carles, Ito, Masaoki, Bracht, Jillian Willhelmina Paulina, Berenguer, Jordi, Chaib, Imane, Molina-Vila, Miguel Angel, Karachaliou, Niki, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2019)

The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer

Por Liang, Hengrui, Pan, Zhenkui, Cai, Xiuyu, Wang, Wei, Guo, Chengye, He, Jiaxi, Chen, Yuehan, Liu, Zhichao, Wang, Bo, He, Jianxing, Liang, Wenhua
Publicado no Transl Lung Cancer Res (2018)

miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition

Por Guo, Huihui, Zhang, Xilin, Chen, Qiuqiang, Bao, Ying, Dong, Chaohui, Wang, Xiang
Publicado no Am J Transl Res (2018)

Differentiation of non-small cell lung cancer and histoplasmosis pulmonary nodules: insights from radiomics model performance compared with clinician observers

Por Uthoff, Johanna, Nagpal, Prashant, Sanchez, Rolando, Gross, Thomas J., Lee, Changhyun, Sieren, Jessica C.
Publicado no Transl Lung Cancer Res (2019)